Short Interest in CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Declines By 49.8%

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the recipient of a significant decline in short interest in January. As of January 31st, there was short interest totalling 12,800 shares, a decline of 49.8% from the January 15th total of 25,500 shares. Based on an average daily volume of 177,200 shares, the short-interest ratio is presently 0.1 days.

CERo Therapeutics Stock Down 17.2 %

Shares of CERo Therapeutics stock traded down $0.00 during trading hours on Thursday, reaching $0.01. 2,661 shares of the company were exchanged, compared to its average volume of 150,756. CERo Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.25. The stock’s fifty day moving average is $0.01 and its 200 day moving average is $0.01.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.